• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

pradhipa.ramanathan@unimelb.edu.au

Credentials


Position
Research Assistant
Department of Microbiology and Immunology
Education
Masters (Coursework & Research)
Universitaet Wuerzburg
Bachelors Degree (Honours)
Anna University
ORCID

0000-0002-7390-8840

Mrs Pradhipa Ramanathan

Research Assistant
Department of Microbiology and Immunology

14 Scholarly works
0 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting
    DOI: 10.1016/j.jinf.2025.106543
  • 2025

    Journal article

    Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4 T-cell and macrophage targets
    DOI: 10.1093/jleuko/qiaf033
  • 2025

    Journal article

    Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant
    DOI: 10.1126/sciadv.ads1482
  • 2025

    Journal article

    P-1972. SARS-CoV-2 Vaccine–Induced IgG4 Response Negatively Correlates with Neutralizing Antibodies and Fc Effector Functions
    DOI: 10.1093/ofid/ofae631.2130
  • 2025

    Journal article

    Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination
    DOI: 10.1038/s41541-025-01268-w
  • 2024

    Journal article

    Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
    DOI: 10.1172/JCI181244
  • 2024

    Journal article

    Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines
    DOI: 10.1016/j.jinf.2024.106119
Pradhipa Ramanathan

RECENT SCHOLARLY WORKS

  • 2023

    Journal article

    Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
    DOI: 10.1016/j.ebiom.2023.104878
  • 2023

    Journal article

    377. Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4th dose boosters
    DOI: 10.1093/ofid/ofad500.447
  • 2023

    Journal article

    Mucosal antibody responses following Vaxzevria vaccination
    DOI: 10.1111/imcb.12685

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224